HNGE vs UNH vs CVS vs ELV vs CI

For growth investors, Hinge Health, Inc.

(HNGE) is the stronger pick with 50. 6% revenue growth year-over-year, versus 7. 8% for CVS Health Corporation (CVS). Cigna Corporation (CI) offers the better valuation at 13. 4x trailing P/E (9. 8x forward), making it the more compelling value choice. Analysts rate Hinge Health, Inc. (HNGE) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Cigna Corporation (CI) is the cheapest at 13.

4x versus CVS Health Corporation at 73. 4x. On forward P/E, Cigna Corporation is actually cheaper at 9. 8x.

Over the past 5 years, Hinge Health, Inc.

(HNGE) delivered a total return of +74. 0%, compared to +11. 7% for UnitedHealth Group Incorporated (UNH). Over 10 years, the gap is even starker: ELV returned +244. 7% versus CVS's +29. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), CVS Health Corporation (CVS) is the lower-risk stock at 0.

19β versus Hinge Health, Inc. 's 1. 32β — meaning HNGE is approximately 594% more volatile than CVS relative to the S&P 500. On balance sheet safety, Hinge Health, Inc. (HNGE) carries a lower debt/equity ratio of 2% versus 124% for CVS Health Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Hinge Health, Inc.

(HNGE) is pulling ahead at 50. 6% versus 7. 8% for CVS Health Corporation (CVS). On earnings-per-share growth, the picture is similar: Cigna Corporation grew EPS 82. 9% year-over-year, compared to -33. 6% for Hinge Health, Inc.. Over a 3-year CAGR, CI leads at 15. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Elevance Health Inc.

(ELV) is the more profitable company, earning 2. 8% net margin versus -89. 9% for Hinge Health, Inc. — meaning it keeps 2. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus -92. 9% for HNGE. At the gross margin level — before operating expenses — HNGE leads at 79. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Cigna Corporation (CI) trades at 9.

8x forward P/E versus 26. 0x for Hinge Health, Inc. — 16. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CI: 14. 9% to $342. 55.

In this comparison, CVS (2.

6% yield), UNH (2. 1% yield), CI (2. 0% yield), ELV (1. 7% yield) pay a dividend. HNGE does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, CVS Health Corporation (CVS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

19), 2. 6% yield). Both have compounded well over 10 years (CVS: +29. 5%, HNGE: +74. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: HNGE is a small-cap high-growth stock; UNH is a large-cap quality compounder stock; CVS is a mid-cap quality compounder stock; ELV is a mid-cap deep-value stock; CI is a mid-cap deep-value stock. UNH, CVS, ELV, CI pay a dividend while HNGE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.